Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
WELIREG Filmtabl 40 mg 90 Stk
Drug
Welireg, Filmtabletten
Von-Hippel-Lindau (VHL) - Krankheit, Fortgeschrittenes Nierenzellkarzinom (RCC)
07.16.4. – others
HAM – Human medicine
FILM – Film-coated tablet
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
3/21/2024
6/30/2030
Dosage strength
Welireg 40 mg, Filmtabletten
Von-Hippel-Lindau (VHL) - Krankheit, Fortgeschrittenes Nierenzellkarzinom (RCC)
01
Z – approved
Package
7680685310019
In trade from / since 3/21/2024
A/R – Authorised / referenced
90 tablet(s)
001
Z – approved
Declaration
Component
40 mg belzutifanum
hypromellosi acetas succinas
cellulosum microcristallinum
mannitolum
carmellosum natricum conexum
silica colloidalis anhydrica
magnesii stearas
poly(alcohol vinylicus)
E 171
macrogolum 3350
talcum
E 132
1.356 mg natrium
cellulosum microcristallinum
mannitolum
carmellosum natricum conexum
silica colloidalis anhydrica
magnesii stearas
poly(alcohol vinylicus)
E 171
macrogolum 3350
talcum
E 132
1.356 mg natrium
Authorisation holder
7601001001138
MSD Merck Sharp & Dohme AG
Werftestrasse 4
6005 Luzern (LU)
Werftestrasse 4
6005 Luzern (LU)
Date of revision of the text
9/17/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.